Clinical Trial Detail

NCT ID NCT02487095
Title Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

lung small cell carcinoma

ovarian cancer

cervical cancer

neuroendocrine tumor

Therapies

Berzosertib

Topotecan

Age Groups: adult

No variant requirements are available.